Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma

Saved in:
Bibliographic Details
Published in:Blood and Lymphatic Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301673526886400
collection WordPress RSS
FRELIP Feed Integration
container_title Blood and Lymphatic Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61065
institution FRELIP
journal_source_facet Blood and Lymphatic Cancer : Targets and Therapy
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_auth Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_full Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_fullStr Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_full_unstemmed Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_short Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_sort phase ii trial of an orelabrutinib-based combination therapy in newly diagnosed primary central nervous system lymphoma
topic Oncology
General
Oncology
url https://www.dovepress.com/phase-ii-trial-of-an-orelabrutinib-based-combination-therapy-in-newly--peer-reviewed-fulltext-article-BLCTT